Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
84.7M
-
Number of holders
-
119
-
Total 13F shares, excl. options
-
54.1M
-
Shares change
-
+462K
-
Total reported value, excl. options
-
$252M
-
Value change
-
+$2.18M
-
Put/Call ratio
-
0.35
-
Number of buys
-
63
-
Number of sells
-
-50
-
Price
-
$4.65
Significant Holders of SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) as of Q2 2023
135 filings reported holding STRO - SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share as of Q2 2023.
SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) has 119 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.1M shares
of 84.7M outstanding shares and own 63.85% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6.01M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (5.88M shares), Rubric Capital Management LP (4.05M shares), BVF INC/IL (3.35M shares), FRANKLIN RESOURCES INC (2.87M shares), VANGUARD GROUP INC (2.83M shares), Holocene Advisors, LP (2.13M shares), Verition Fund Management LLC (1.95M shares), BAILLIE GIFFORD & CO (1.87M shares), and Samsara BioCapital, LLC (1.68M shares).
This table shows the top 119 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.